MyJSCAI Profile Banner
MyJSCAI Profile
MyJSCAI

@MyJSCAI

Followers
10K
Following
2K
Media
2K
Statuses
2K

The official scientific journal of @SCAI. EIC: Alexandra Lansky, MD, MSCAI

Washington, DC
Joined November 2017
Don't wanna be here? Send us removal request.
@MyJSCAI
MyJSCAI
1 year
🚨Exciting News! #JSCAI is accepted for PubMed Central Indexing!🎉 Read @AlexandraLansky's editorial: ➡️ https://t.co/R70gqqHc5O 📢This significant milestone boosts our authors' visibility, citation rates, and recognition by making all articles more accessible to researchers
11
23
92
@M_Pompeu_Sa_MD
Michel Pompeu Sá
2 days
🔥Hot off the press🔥 Read our new Bayesian meta-analysis just published in @MyJSCAI #JSCAI about cerebral protection devices (CEP) in #TAVR https://t.co/8HqnqlpXNq Take-🏠 message: CEP not associated with statistically significant reduction in 🧠stroke risk. The Bayesian
0
5
15
@singapore_edb
Singapore EDB
2 months
Find out how is SG leading Southeast Asia’s energy transition through increased renewable financing and project development, production as well as distribution.
5
3
106
@MyJSCAI
MyJSCAI
2 days
📖New NACMI Registry Insights in #JSCAI - Baseline ECG Outperforms the #Angiogram for Predicting Mortality in #COVID19–Associated #STEMI💡 ➡️ https://t.co/aaJFn4r5oE @BaineyKevin @dehghani_payam @rgarberich @anna_bortnick @chadialraies @HenrytTimothy
1
5
12
@MyJSCAI
MyJSCAI
4 days
📖Percutaneous mechanical atherothrombectomy vs arterial bypass surgery for femoropopliteal #InStentRestenosis & occlusion: a budget impact analysis from the perspective of a UK vascular service 💡read more⬇️ ➡️ https://t.co/ATMfMcedwX #PMA #ISR
0
1
4
@MyJSCAI
MyJSCAI
8 days
📖Patient voices reveal what really matters in #CAD care: QoL, trust, & clear communication. Key lessons from RECHARGE to improve trial design & equity. #PCI #CABG 💡Read more: ➡️ https://t.co/BtUfnxOgWw @RuthMCreber @StephanieNDR @jspertus @GreggWStone @BjornRedfors
0
3
7
@caffeineai
caffeine
1 day
No dev team? No problem. Caffeine turns your ideas into launch-ready apps — just by chatting. Start for free →
1
2
18
@MyJSCAI
MyJSCAI
10 days
🆕Watch @SCAI experts Drs. Cindy Grines, @Kandzari, @kinimai, & @AlQarqazM break down the key insights from the Ringer Study—a prospective, multicenter evaluation of the Ringer perfusion catheter, a spiral balloon designed to control coronary artery perforation.
0
3
19
@VIVAPhysicians
The VIVA Foundation
10 days
0
2
4
@VIVAPhysicians
The VIVA Foundation
10 days
At #VIVA25, a powerhouse panel—Drs. @EricSecemskyMD, @ehrin_armstrong, @sahilparikhmd, @ChandraVenita, and @saherssabri—broke down why CLTI demands urgent, unified attention. From rising amputation trends to major gaps in access, the message was clear: multispecialty
1
3
6
@MyJSCAI
MyJSCAI
10 days
📖Elevated #LVEDP (>20 mmHg) is associated with higher one-year mortality post-#PCI in #CCS & #ACS; higher mortality with #LVEF <40%. ➡️ https://t.co/gZ0IB35elm @DoctorKini @Drroxmehran @georgedangas @samtori @AngeloOliva3 @Cathdoctor #LeftVentricularEndDiastolicPressure
0
3
8
@DrFrankTurek
Frank Turek
11 days
Want to share the Gospel this holiday season without causing family drama? I’ve got you! Download my FREE Truth at the Table Toolkit for simple, loving ways to point your family to Jesus
0
3
14
@MyJSCAI
MyJSCAI
11 days
📑Retrograde Crossing Facilitating Rotational Atherectomy for Recanalization of Uncrossable Aorto-Ostial #CTO Staged #PCI with RA (RotaWire Extra Support) was ultimately successful after an unsuccessful retrograde crossing attempt. 💡 ➡️ https://t.co/hcW0tAxFL9 @minpinghuang1
0
1
2
@MyJSCAI
MyJSCAI
17 days
📖#InterventionalCardiology & #HeartFailure partner to care for patients across the spectrum of #HF care. In this comprehensive review, co-authors discuss how interventions can be used to promote #equity in #HF. Read more💡 ➡️ https://t.co/2oMMjjUr6c @QuentinYoumans
2
4
8
@MyJSCAI
MyJSCAI
18 days
📖Women undergoing #intravascular brachytherapy for #ISR had higher rates of target lesion revascularization, #MI & MACE vs men despite similar procedures. Highlights need for sex-specific strategies💡 ➡️ https://t.co/MLE1m4xrTg @KrityaMangesh @KharsaChloe @AlpeshShahMD
0
3
11
@MyJSCAI
MyJSCAI
18 days
📖💡Meta analysis of 11 RCT & observational studies indicates a lower risk of target lesion failure with #DCB vs plain old #balloon #angioplasty/#DES TLF, RR 0.52 (95% CI: 0.40–0.68, p < 0.0001). ➡️ https://t.co/IGL3hhGQl5 @ASlotwiner @boutroskaram1 @LouaiRazzouk @BinitaShahMD
1
5
11
@MyJSCAI
MyJSCAI
24 days
📰 The November issue of #JSCAI has been released! Read the latest studies, research, and expert opinions now. ➡️Read the issue: https://t.co/cboA0LtB9N
0
2
6
@MyJSCAI
MyJSCAI
30 days
📖Respiratory support is linked to increased mortality across all #SCAI #CardiogenicShock stages. It may serve as a simple, easily identifiable #ShockClassification modifier #CritCareCards #CICU 💡Read More: ➡️ https://t.co/nLneEb3yy3 @TalalZarif1 @CesarCaraballoC @AYOKUNLE_MD
2
3
23
@NotreDame
University of Notre Dame
2 months
Glioblastoma is an aggressive brain cancer with limited treatment options. On average, patients survive only 18 months after diagnosis. Notre Dame Engineering Professor Meenal Datta is using microgravity in space to accelerate tumor research and uncover new therapies.
0
1
16
@MyJSCAI
MyJSCAI
1 month
📖Protamine use during #CTO - #PCI linked to fewer deaths/tamponade with no ↑ stent thrombosis risk. First study in this setting Read more 💡#InterventionalCardiology ➡️ https://t.co/d8l4zARQQd @AkashPatelMDMBA @ahmednabil9620 @jamiemccabeMD @DrBillLombardi @Ravi_Hira_MD
0
4
14
@PWesslyMD
Priscilla Wessly
1 month
Thrilled to share our new publication in @MyJSCAI from the 2024–2025 #ACCCTR and REACH cohorts! 🫀 ⚖️ 50% women | 25% Hispanic 🌱 52% gained new mentorship|🤝 81% new collaborations 💡 79% new research opportunities The #ACCCTR & REACH programs are advancing equity, mentorship,
4
11
31
@MyJSCAI
MyJSCAI
1 month
📑Trials for #PulmonaryEmbolism are representative of the disease population, compared to other areas of #cardiovascular medicine #PE #HealthEquity Read more💡 ➡️ https://t.co/lhwA2LXrvJ @reh84315851 @TaiKobayashiMD @jaygirimd @TayyabShahMD
1
4
5
@MyJSCAI
MyJSCAI
1 month
📖PVAD-supported high-risk #PCI in non-shock patients may be associated with improved clinical out-comes compared with #IABP support 💡Read more ⤵️ ➡️ https://t.co/JdYtS6kRM0 @AlexandraLansky @TayyabShahMD @JWMoses @AlejandroLemor @BillONeillMD
1
2
5
@Rentacomputer
Rentacomputer.com
1 month
Computers, Servers, iPads, Displays, Hotspots, and Much More. No matter what you need, we have it -- all in one place.
0
4
23
@MyJSCAI
MyJSCAI
1 month
🚨🔍 New 2-part series from the VIVA Foundation’s 2024 #Vascular Leaders Forum on #CLTI care: collaboration across specialties & care settings + optimizing clinical trial data to improve pt outcomes. 👉 Part 1: Multispecialty collaboration in CLTI care 👉 Part 2: Designing
0
3
5
@MyJSCAI
MyJSCAI
1 month
📖National data from 2018–'22 -experts found significant racial & ethnic disparities in #Tricuspid #Transcatheter edge-to-edge repair outcomes. ⚫ Black patients had higher complication rates. 🟤 Black & Hispanic patients had longer hospital stays. The findings call for action
1
2
4